{"filing":{"accession_number":"0001193125-26-272710","cik":"0001661181","ticker":"ORGO","company_name":"Organogenesis Holdings Inc.","form":"8-K","filing_date":"2026-06-16","report_date":null,"primary_document":"d66140d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1661181/000119312526272710/d66140d8k.htm"},"events":[{"id":11347,"run_id":9963,"accession_number":"0001193125-26-272710","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Organogenesis Holdings held its 2026 Annual Meeting of Stockholders on June 15, 2026, with voting results on three proposals: election of nine directors, advisory approval of named executive officer compensation, and ratification of RSM US LLP as independent auditor.","company_name":"Organogenesis Holdings Inc.","ticker":"ORGO","filing_date":"2026-06-16","form":"8-K","submitted_at":null,"items":[{"id":7912,"accession_number":"0001193125-26-272710","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":false,"confidence":0.75,"reasoning":"The disclosure reports the re-election of Garrett Lustig to the board of directors by Series A Convertible Preferred Stock holders on June 15, 2026. While this is technically an appointment action, it is a routine re-election of an existing director with no indication of new compensation, material changes, or other substantive developments. The filing incorporates by reference the April 30, 2026 Proxy Statement, suggesting this is a standard governance matter rather than a material event requiring standalone disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-16T20:34:08.265668+00:00","company_name":"","ticker":null,"filing_date":""},{"id":7913,"accession_number":"0001193125-26-272710","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the results of Organogenesis Holdings' 2026 Annual Meeting of Stockholders held on June 15, 2026, with detailed voting tallies for three proposals: election of nine directors, advisory approval of named executive officer compensation, and ratification of RSM US LLP as independent auditor. The filing directly matches the shareholder_vote_results event type, which covers results of votes at annual or special meetings of security holders.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-16T20:34:08.265668+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":7912,"accession_number":"0001193125-26-272710","item_number":"5.02","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":false,"confidence":0.75,"reasoning":"The disclosure reports the re-election of Garrett Lustig to the board of directors by Series A Convertible Preferred Stock holders on June 15, 2026. While this is technically an appointment action, it is a routine re-election of an existing director with no indication of new compensation, material changes, or other substantive developments. The filing incorporates by reference the April 30, 2026 Proxy Statement, suggesting this is a standard governance matter rather than a material event requiring standalone disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-16T20:34:08.265668+00:00","company_name":"Organogenesis Holdings Inc.","ticker":"ORGO","filing_date":"2026-06-16"},{"id":7913,"accession_number":"0001193125-26-272710","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the results of Organogenesis Holdings' 2026 Annual Meeting of Stockholders held on June 15, 2026, with detailed voting tallies for three proposals: election of nine directors, advisory approval of named executive officer compensation, and ratification of RSM US LLP as independent auditor. The filing directly matches the shareholder_vote_results event type, which covers results of votes at annual or special meetings of security holders.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-16T20:34:08.265668+00:00","company_name":"Organogenesis Holdings Inc.","ticker":"ORGO","filing_date":"2026-06-16"}]}